Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeWages, Salaries and Other
Others
Ratios

Aethlon Medical (AEMD) Profit After Tax (2016 - 2025)

Aethlon Medical (AEMD) has disclosed Profit After Tax for 15 consecutive years, with -$6.3 million as the latest value for Q1 2025.

  • For the quarter ending Q1 2025, Profit After Tax fell 157.89% year-over-year to -$6.3 million, compared with a TTM value of -$13.4 million through Mar 2025, down 9.66%, and an annual FY2025 reading of -$13.4 million, down 9.66% over the prior year.
  • Profit After Tax was -$6.3 million for Q1 2025 at Aethlon Medical, down from -$1.8 million in the prior quarter.
  • Across five years, Profit After Tax topped out at -$1.8 million in Q4 2024 and bottomed at -$6.3 million in Q1 2025.
  • Average Profit After Tax over 5 years is -$3.0 million, with a median of -$2.8 million recorded in 2024.
  • The sharpest move saw Profit After Tax skyrocketed 49.37% in 2024, then plummeted 157.89% in 2025.
  • Year by year, Profit After Tax stood at -$2.5 million in 2021, then fell by 12.73% to -$2.8 million in 2022, then fell by 21.63% to -$3.5 million in 2023, then soared by 49.37% to -$1.8 million in 2024, then tumbled by 256.45% to -$6.3 million in 2025.
  • Business Quant data shows Profit After Tax for AEMD at -$6.3 million in Q1 2025, -$1.8 million in Q4 2024, and -$2.8 million in Q3 2024.